Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04533165 · ClinicalTrials.gov registry record · NA

Virtual Exercise Program to Reduce Cancer Related Fatigue

A NA study of Cancer and Fatigue, sponsored by University of Colorado, Denver.

Active
Registry status
NA
Development phase
19
Enrollment target
1
Study location

NCT04533165: Active NA study of Cancer and Fatigue, sponsored by University of Colorado, Denver.

NCT04533165 is a NA study of Cancer and Fatigue that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 19 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04533165, a NA study of Cancer and Fatigue, is active but no longer recruiting, sponsored by University of Colorado, Denver.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
19 participants
Enrollment target
1
Study location

Study Summary

The objective of this investigation is to establish the feasibility and initial effectiveness of a novel exercise program for rural cancer survivors in Colorado suffering from cancer related fatigue. Participation in an exercise program has regularly been shown to reduce fatigue in cancer survivors, though in-person, supervised participation has a greater effect on fatigue than home-based programs with no supervision. Access to these supervised programs are limited in rural areas, restricting the ability of rural cancer survivors to experience the fatigue-reducing benefits of exercise. The proposed program will use information on improvements in fatigue from participants in the BfitBwell Cancer Exercise Program to monitor improvements in fatigue in rural cancer survivors performing a home exercise program and trigger a telehealth session with a cancer exercise specialist to adapt the exercise prescription when improvements are less than expected. The BfitBwell Program is an established exercise program at the Anschutz Health and Wellness Center which has worked with over 600 cancer survivors and is highly effective at reducing cancer related fatigue. The goal of the program is to replicate the effects of a successful supervised exercise program in rural cancer survivors who do not have access to this type of program. This investigation will recruit 20 rural cancer survivors experiencing fatigue and assess their ability to participate in the program, as well as how well the program improves their fatigue. Interviews will be conducted with participants after the program to determine how future versions of the program could be improved. The investigators anticipate that this program will be feasible and effective, providing preliminary data to pursue a large-scale clinical trial of the program following this project's completion.

Primary Outcome

13-item instrument widely used to assess cancer related fatigue. Score range: 0-52. Lower scores indicate more fatigue.

Interventions

  • BEHAVIORAL Exercise

Study Locations (1)

Colorado

  • Anschutz Health and Wellness - Aurora

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2021-11-11
Est. Completion 2026-05
Phase NA
University of Colorado, Denver

1,283 total trials

What the registry record for NCT04533165 still lists

NCT04533165 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower).

The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Exercise is the first listed.

NCT04533165 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT04533165 about?

NCT04533165 is a clinical study titled "Virtual Exercise Program to Reduce Cancer Related Fatigue". The objective of this investigation is to establish the feasibility and initial effectiveness of a novel exercise program for rural cancer survivors in Colorado suffering from cancer related fatigue. Participation in an exercise program has regularly been shown to reduce fatigue in cancer survivors,...

What is the current status of trial NCT04533165?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 19 participants. The study started on 2021-11-11. Estimated completion is 2026-05.

What conditions does trial NCT04533165 study?

This clinical trial studies the following conditions: Cancer, Fatigue, Cancer-related Problem/Condition.

What interventions are being tested in trial NCT04533165?

The interventions under investigation include: Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT04533165?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04533165 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04533165's enrollment target sits among peer trials

19 570th of 615 higher than 45 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04533165, the US trial registry maintained by the National Library of Medicine. NCT04533165 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.